We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Novel Method Prepares Tissue Samples for Analyzing Proteins

By LabMedica International staff writers
Posted on 23 Apr 2014
Print article
Image: Immunostaining of human lung tissue, fixed with HOPE, from a patients suffering from legionnaire\'s disease. One legionella protein (red-brown), the bacteria-containing vacuoles and individual legionella inside the scavenger cells can be detected. The infection process can be observed immediately using proteomics (Photo courtesy of Braunschweig University of Technology).
Image: Immunostaining of human lung tissue, fixed with HOPE, from a patients suffering from legionnaire\'s disease. One legionella protein (red-brown), the bacteria-containing vacuoles and individual legionella inside the scavenger cells can be detected. The infection process can be observed immediately using proteomics (Photo courtesy of Braunschweig University of Technology).
A new way of preparing patient tissue for analyses might soon become the new standard, possibly replacing tissues fixed with formalin, before they are embedded in wax-like paraffin and cut into razor-thin slices.

The new method allows tissue samples to be treated such that they do not only meet the requirements of clinical histology, but can still be characterized later on by modern methods of proteomics, a technique analyzing all proteins at once.

Scientists at the Helmholtz Center for Infection Research (Braunschweig, Germany) obtained lung tissue samples from surgery patients. From each donor one piece of lung tissue was immediately frozen in liquid nitrogen and the other piece was fixed using the Hepes-glutamic acid buffer mediated Organic solvent Protection Effect or HOPE technique (DCS Diagnostics; Hamburg, Germany).

For proteomic analyses the HOPE fixed and snap frozen lung samples were homogenized, sonicated, and centrifuged. After estimating protein content, the proteins were digested and phosphopeptide enriched. The peptides were analyzed on an UltiMate 3000 RSLC nano LC system connected to an LTQ Orbitrap Velos Pro mass spectrometer (Thermo Scientific, Waltham, MA, USA).

The team found that in contrast to snap-frozen samples, HOPE fixation preserves the structure of tissues well and for example lung vesicles can be seen more clearly. They used mass spectrometry in order to characterize the proteins that are present in the tissue. The proteome derived from this study tells much about the health status of the tissue. The scientists went one step further and also investigated the so-called phosphoproteome which is all protein molecules in the cell that are currently switched on or off. To know which proteins are active contributes to the diagnosis of diseases and can help identify targets for new medications. The results are very promising: HOPE fixation does not only preserve the structure of the tissue but is just as well-suited for proteomics and phosphoproteomics as snap-freezing the tissue.

Lothar Jänsch, PhD, a professor and the senior author of the study said, “Based on our results, we recommend HOPE as the fixation strategy for clinics and biobanks that are actively involved in improving diagnosis and therapies.” The team of investigators applied this novel method also to studies on legionnaire's disease, an infectious disease that is caused by bacteria and is associated with pneumonia. The authors recommend HOPE generally as the “fixative of choice” for studies aiming to describe molecular features of human tissues at the systems level. HOPE fixation opens promising avenues for a better understanding of human diseases and best matches perspective requirements for personalized clinical analytics. The study was published on April 7, 2014, in the Journal of Proteome Research.

Related Links:

Helmholtz Centre for Infection Research
DCS Diagnostics
Thermo Scientific


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.